Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA, 15 Plate

Images

 

Product Details

Summary
Reactivity HuSpecies Glossary
Applications ELISA
Conjugate
Biotin

Order Details

Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA, 15 Plate Summary

Source
N/A
Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details
Gene
IFNL1

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
No significant interference observed with available related molecules.
Publications
Read Publications using DY1598B.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA, 15 Plate

  • IFNl1
  • IFNl3
  • IFNlambda 1
  • IFNlambda 3
  • IL-29/IL-28B (IFN-lambda 1/3)

Background

Human/mouse IL-28A (IFN-lambda 2), IL-28B (IFN-lambda 3), and human IL-29 (IFN-lambda 1) are class II cytokine receptor ligands that are distantly related to members of the IL-10 family (11 - 13% amino acid (aa) sequence identity) and type I IFN family (15 - 19% aa sequence identity). These cytokines exert bioactivities that overlap those of type I IFNs, including antiviral activity and up-regulation of MHC class I antigen expression. The proteins signal through the same heterodimeric receptor complex that is composed of the IL-10 receptor beta (IL-10 R beta) and a novel IL-28 receptor alpha (IL-28 R alpha, also known as IFN-lambda R1). Mouse IL-28 shares 61%, 62%, and 52% aa identity with human IL-28A, IL-28B, and IL-29, respectively.

Publications for IL-29/IL-28B IFN-lambda 1/3) (DY1598B)(32)

We have publications tested in 2 confirmed species: Human, Primate.


Filter By Application
All Applications
Filter By Species
Human
(31)
Primate
(1)
All Species
Showing Publications 1 - 10 of 32. Show All 32 Publications.
Publications using DY1598B Applications Species
Reuschl, AK;Thorne, LG;Whelan, MVX;Ragazzini, R;Furnon, W;Cowton, VM;De Lorenzo, G;Mesner, D;Turner, JLE;Dowgier, G;Bogoda, N;Bonfanti, P;Palmarini, M;Patel, AH;Jolly, C;Towers, GJ; Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants Nature microbiology 2024-01-16 [PMID: 38228858] (Human) Human
De, M;Sukla, S;Bharatiya, S;Keshri, S;Roy, DG;Roy, S;Dutta, D;Saha, S;Ejazi, SA;Ravichandiran, V;Ali, N;Chatterjee, M;Chinnaswamy, S; IFN-?3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans Infection and immunity 2024-01-09 [PMID: 38193711] (Human) Human
Schutt, WR;Conde, JN;Mladinich, MC;Himmler, GE;Mackow, ER; ZIKV induction of tristetraprolin in endothelial and Sertoli cells post-transcriptionally inhibits IFN?/? expression and promotes ZIKV persistence mBio 2023-09-14 [PMID: 37707056] (Human) Human
Sugimoto, A;Numaguchi, T;Chihama, R;Takenaka, Y;Sato, Y; Identification of novel lactic acid bacteria with enhanced protective effects against influenza virus PloS one 2023-08-09 [PMID: 37556447] (Human) Human
H Stölting, L Baillon, R Frise, K Bonner, RJ Hewitt, PL Molyneaux, ML Gore, Breathing, WS Barclay, S Saglani, CM Lloyd Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1 Mucosal Immunology, 2022-07-15;0(0):. 2022-07-15 [PMID: 35840680] (Human) Human
A Steiner, K Hrovat-Sch, I Prigione, CH Yu, P Laohamonth, CR Harapas, RRJ Low, D De Nardo, LF Dagley, MJ Mlodzianos, KL Rogers, T Zillinger, G Hartmann, MP Gantier, M Gattorno, M Geyer, S Volpi, S Davidson, SL Masters Deficiency in coatomer complex I causes aberrant activation of STING signalling Nature Communications, 2022-04-28;13(1):2321. 2022-04-28 [PMID: 35484149] (Human) Human
Y Song, G Hou, J Diep, YS Ooi, NS Akopyants, SM Beverley, JE Carette, HB Greenberg, S Ding Inhibitor of growth protein 3 epigenetically silences endogenous retroviral elements and prevents innate immune activation Nucleic Acids Research, 2021-12-16;0(0):. 2021-12-16 [PMID: 34791430] (Human) Human
SJ Oh, OS Shin SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response Cells, 2021-03-02;10(3):. 2021-03-02 [PMID: 33801464] (Human) Human
MR Hendricks, S Lane, JA Melvin, Y Ouyang, DB Stolz, JV Williams, Y Sadovsky, JM Bomberger Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infection Cell Reports, 2021-01-26;34(4):108672. 2021-01-26 [PMID: 33503419] (Human) Human
K Hjorton, N Hagberg, P Pucholt, ML Eloranta, L Rönnblom The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells Arthritis Res. Ther., 2020-06-05;22(1):130. 2020-06-05 [PMID: 32503683] (Human) Human
Show All 32 Publications.

Reviews for IL-29/IL-28B IFN-lambda 1/3) (DY1598B) (0)

There are no reviews for IL-29/IL-28B IFN-lambda 1/3) (DY1598B). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for IL-29/IL-28B IFN-lambda 1/3) (DY1598B) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional IL-29/IL-28B IFN-lambda 1/3) Products

Blogs on IL-29/IL-28B IFN-lambda 1/3)

There are no specific blogs for IL-29/IL-28B IFN-lambda 1/3), but you can read our latest blog posts.

Contact Information

Product PDFs

Review this Product

Be the first to review our Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA, 15 Plate and receive a gift card or discount.

Bioinformatics

Gene Symbol IFNL1